SAN DIEGO, Calif.--(BUSINESS WIRE)--Function Oncology, a precision medicine company advancing a CRISPR-powered personalized functional genomics platform to transform the future of targeted cancer ...
In modern functional genomics, understanding how specific genes control cellular behavior requires both targeted intervention and high-resolution analysis. That’s where Perturb-Seq comes in—a method ...
Precision medicine company Function Oncology has officially launched with the goal of revolutionizing the future of targeted cancer treatment by developing a CRISPR-powered, personalized functional ...
SAN DIEGO & BERLIN & DURHAM, N.C.--(BUSINESS WIRE)--Vividion Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing novel discovery technologies to unlock high-value, traditionally ...
New research suggests that large language models like GPT-4 could streamline the process of gene set enrichment, an approach what genes do and how they interact. Results bring science one step closer ...
The Milner Therapeutics Institute launched a new functional genomics screening laboratory (FGSL) in Cambridge, U.K. The lab will support research and innovation in functional genomics, which explores ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback